Chinese Heparin Allowed In U.S. By FDA Failure, Report Says
This article was originally published in PharmAsia News
Executive Summary
China-made heparin, linked to more than 80 deaths in the United States recently, was allowed on the U.S. market in part by a U.S. FDA failure to respond to early reports of problems